BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32146745)

  • 41. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
    Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
    Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
    Baecklund E; Backlin C; Rönnelid J; Toes R; Huizinga T; Åhlin E; Askling J; Hochberg FH; Klareskog L; Kay J; Smedby KE
    Scand J Rheumatol; 2018 Jul; 47(4):270-275. PubMed ID: 29336646
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study on the mortality and risk factors among HIV/AIDS patients receiving antiretroviral therapy in Xinjiang Uygur Autonomous Region].
    Ni M; Chen X; Hu X; Ma Y
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Nov; 48(11):953-8. PubMed ID: 25582364
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autoimmune diabetes in HIV-infected patients on highly active antiretroviral therapy.
    Takarabe D; Rokukawa Y; Takahashi Y; Goto A; Takaichi M; Okamoto M; Tsujimoto T; Noto H; Kishimoto M; Kaburagi Y; Yasuda K; Yamamoto-Honda R; Tsukada K; Honda M; Teruya K; Kajio H; Kikuchi Y; Oka S; Noda M
    J Clin Endocrinol Metab; 2010 Aug; 95(8):4056-60. PubMed ID: 20484483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Epidemiological and clinical features of occult hepatitis B in HIV infection without antiretroviral treatment].
    Zhang RF; Liu L; Zheng YF; Shen YZ; Chen J; Gu SM; Wang JR; Lu HZ
    Zhonghua Gan Zang Bing Za Zhi; 2013 Mar; 21(3):189-91. PubMed ID: 23967739
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients.
    Meyer PWA; Ally MTM; Hodkinson B; Anderson R; Tikly M
    Rheumatol Int; 2018 Jun; 38(6):993-1001. PubMed ID: 29713794
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease.
    Chen F; Day SL; Metcalfe RA; Sethi G; Kapembwa MS; Brook MG; Churchill D; de Ruiter A; Robinson S; Lacey CJ; Weetman AP
    Medicine (Baltimore); 2005 Mar; 84(2):98-106. PubMed ID: 15758839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It.
    Steve RJ; Alex D; Yesudhason BL; Prakash JAJ; Mathews NS; Daniel D; Ramalingam VV; Demosthenes JP; Ghale BC; Anantharam R; Rebekah G; Rupali P; Varghese GM; Kannangai R
    Curr HIV Res; 2021; 19(3):277-285. PubMed ID: 33596809
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal humoral immune response to influenza vaccination in pediatric type-1 human immunodeficiency virus infected patients receiving highly active antiretroviral therapy.
    Montoya CJ; Toro MF; Aguirre C; Bustamante A; Hernandez M; Arango LP; Echeverry M; Arango AE; Prada MC; Alarcon Hdel P; Rojas M
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):501-8. PubMed ID: 17612772
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.
    Cohen Stuart JW; Velema M; Schuurman R; Boucher CA; Hoepelman AI
    J Med Virol; 2009 Mar; 81(3):441-5. PubMed ID: 19152397
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Autoantibodies in patients with psoriatic arthritis on anti-TNFα therapy.
    Viana VS; de Carvalho JF; de Moraes JC; Saad CG; Ribeiro AC; Gonçalves C; Bueno C; Vendramini MB; Bonfá E
    Rev Bras Reumatol; 2010; 50(3):225-34. PubMed ID: 21125159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antinuclear antibodies in infectious diseases.
    Im JH; Chung MH; Park YK; Kwon HY; Baek JH; Lee SY; Lee JS
    Infect Dis (Lond); 2020 Mar; 52(3):177-185. PubMed ID: 31718355
    [No Abstract]   [Full Text] [Related]  

  • 55. Diagnostic utility of anti-cyclic citrullinated peptide and anti-modified citrullinated vimentin antibodies in rheumatoid arthritis.
    Keskin G; Inal A; Keskin D; Pekel A; Baysal O; Dizer U; Sengül A
    Protein Pept Lett; 2008; 15(3):314-7. PubMed ID: 18336364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study.
    Atzeni F; Sarzi-Puttini P; Dell' Acqua D; de Portu S; Cecchini G; Cruini C; Carrabba M; Meroni PL
    Arthritis Res Ther; 2006; 8(1):R3. PubMed ID: 16356192
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 58. No evidence of autoimmunity in 6-year-old children immunized at birth with recombinant hepatitis B vaccine.
    Belloni C; Avanzini MA; De Silvestri A; Martinetti M; Pasi A; Coslovich E; Autelli M; Masanti ML; Cuccia M; Tinelli C; Rondini G; Lorini R
    Pediatrics; 2002 Jul; 110(1 Pt 1):e4. PubMed ID: 12093985
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
    Bruns A; Nicaise-Roland P; Hayem G; Palazzo E; Dieudé P; Grootenboer-Mignot S; Chollet-Martin S; Meyer O
    Joint Bone Spine; 2009 May; 76(3):248-53. PubMed ID: 19208451
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
    Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
    J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.